Ten‐day triple therapy versus sequential therapy versus concomitant therapy as first‐line treatment for Helicobacter pylori infection

Publisher： John Wiley & Sons Inc

E-ISSN： 1440-1746|30|7|1134-1139

ISSN： 0815-9319

Source： JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol.30, Iss.7, 2015-07, pp. : 1134-1139

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety of One-week, First-line, Standard Triple Therapy for Helicobacter pylori Eradication in a Japanese Population

By  

Current Drug Safety, Vol. 12, Iss. 2, 2017-07 ,pp. : 103-109

Bentham Science Publishers

Access to resources Recommend Favorite

Sequential or concomitant therapy for eradication of Helicobacter pylori infection: A systematic review and meta‐analysis

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 9, 2015-09 ,pp. : 1338-1345

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sequential vs. prolonged 14‐day triple therapy for Helicobacter pylori eradication: the meta‐analysis may be influenced by ‘geographical weighting’

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 1368-5031, Iss. 10, 2015-10 ,pp. : 1112-1120

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sequential vs. prolonged 14‐day triple therapy for Helicobacter pylori eradication: the meta‐analysis may be influenced by ‘geographical weighting’

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. 10, 2015-10 ,pp. : 1112-1120

John Wiley & Sons Inc

Access to resources Recommend Favorite

Concomitant and hybrid therapy for Helicobacter pylori infection: A randomized clinical trial

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 9, 2015-09 ,pp. : 1361-1366

John Wiley & Sons Inc

Access to resources Recommend Favorite